Oral and Long-Acting Injectable Cabotegravir Preexposure Prophylaxis Use Among U.S. Veterans Using Veterans Health Administration Services, 2021-2025 (306339)

Study identification

• EU PAS number:
  EUPAS1000000939
• Study ID:
  1000000939
• Official title and acronym:
  Oral and Long-Acting Injectable Cabotegravir Preexposure Prophylaxis Use Among U.S. Veterans Using Veterans Health Administration Services, 2021-2025 (306339)
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  No information provided.
• Study status:
  Planned

Research institutions and networks

Institutions

ViiV Healthcare

Study timelines

Date when funding contract was signed

Actual:15/09/2025

Study start date

Planned:25/02/2026

Date of final study report

Planned:30/09/2027

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

ViiV Healthcare Company

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable